Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Prasse

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Pneumologie (Stuttgart, Germany)|February 22, 2018
[DGP Interstitial Lung Disease Patient Questionnaire]M Kreuter, U Ochmann, D Koschel, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|March 7, 2013
Endpoints for clinical trials of sarcoidosisR P Baughman, M Drent, D A Culver, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|July 30, 2011
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task ForceR P Baughman, S Nagai, M Balter, et al.
Pneumologie (Stuttgart, Germany)|August 1, 2015
[Position Paper: Significance of the Forced Vital Capacity in Idiopathic Pulmonary Fibrosis]J Behr, F Bonella, R Bonnet, et al.
Pneumologie (Stuttgart, Germany)|May 19, 2020
[German Guideline for Idiopathic Pulmonary Fibrosis]J Behr, A Günther, F Bonella, et al.
Pneumologie (Stuttgart, Germany)|April 1, 2020
[German Guideline for Idiopathic Pulmonary Fibrosis]J Behr, A Günther, F Bonella, et al.
Pneumologie (Stuttgart, Germany)|January 18, 2013
[German guideline for diagnosis and management of idiopathic pulmonary fibrosis]J Behr, A Günther, W Ammenwerth, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Pneumologie (Stuttgart, Germany)|February 22, 2018
[DGP Interstitial Lung Disease Patient Questionnaire]M Kreuter, U Ochmann, D Koschel, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|March 7, 2013
Endpoints for clinical trials of sarcoidosisR P Baughman, M Drent, D A Culver, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|July 30, 2011
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task ForceR P Baughman, S Nagai, M Balter, et al.
Pneumologie (Stuttgart, Germany)|August 1, 2015
[Position Paper: Significance of the Forced Vital Capacity in Idiopathic Pulmonary Fibrosis]J Behr, F Bonella, R Bonnet, et al.
Pneumologie (Stuttgart, Germany)|May 19, 2020
[German Guideline for Idiopathic Pulmonary Fibrosis]J Behr, A Günther, F Bonella, et al.
Pneumologie (Stuttgart, Germany)|April 1, 2020
[German Guideline for Idiopathic Pulmonary Fibrosis]J Behr, A Günther, F Bonella, et al.
Pneumologie (Stuttgart, Germany)|January 18, 2013
[German guideline for diagnosis and management of idiopathic pulmonary fibrosis]J Behr, A Günther, W Ammenwerth, et al.
Pageof 5